Evidence map›Paper›PMID 32623786›Full record

ArticleJournal of neuroscience research2020

Lrrk2 modulation of Wnt signaling during zebrafish development.

Jinelle M Wint, Howard I Sirotkin

Open access · greenAbstract read
In one paragraph

Article in Journal of neuroscience research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jinelle M WintMolecular and Cellular Biology Graduate Program, Stony Brook University, Stony Brook, NY, USA.
Howard I SirotkinDepartment of Neurobiology & Behavior, Stony Brook University, Stony Brook, NY, USA.ORCID 0000-0002-1428-867X
Stony Brook University · US

Funding

Development of a Zebrafish PD Drug Discovery PlatformR03NS102949 · NINDS · STATE UNIVERSITY NEW YORK STONY BROOK · PI SIROTKIN, HOWARD I · 2017 to 2018
$154k
NINDS NIH HHS R03 NS102949
6 · The paper itself

Abstract

Mutations in leucine-rich repeat kinase 2 (lrrk2) are the most common genetic cause of Parkinson's disease. Difficulty in elucidating the pathogenic mechanisms resulting from disease-associated Lrrk2 variants stems from the complexity of Lrrk2 function and activities. Lrrk2 contains multiple protein-protein interacting domains, a GTPase domain, and a kinase domain. Lrrk2 is implicated in many cellular processes including vesicular trafficking, autophagy, cytoskeleton dynamics, and Wnt signaling. Here, we generated a zebrafish lrrk2 allelic series to study the requirements for Lrrk2 during development and to dissect the importance of its various domains. The alleles are predicted to encode proteins that either lack all functional domains (lrrk2

Indexed as

Amino Acid SequenceAnimalsAnimals, Genetically ModifiedEmbryonic DevelopmentFluorescent DyesLeucine-Rich Repeat Serine-Threonine Protein Kinase-2MutationWnt Signaling PathwayZebrafishZebrafish ProteinsFluorescent DyesLeucine-Rich Repeat Serine-Threonine Protein Kinase-2LRRK2 protein, zebrafishZebrafish ProteinsCRISPR-Cas9Lrrk2Parkinson's diseaseWntzebrafish

Identifiers

PMID32623786
PMCPMC7643907
OpenAlexW3039281613

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.